[IR-H-(PHCN)[KAPA(2)-(C,O)-CH=CHC(ET)=O]-(PPH3)2]-CLO4
Compound with spectra: 1 NMR
![[IR-H-(PHCN)[KAPA(2)-(C,O)-CH=CHC(ET)=O]-(PPH3)2]-CLO4](/api/compound/I2vkRHi6o6g.png?ph=true&h=300&w=458 "[IR-H-(PHCN)[KAPA(2)-(C,O)-CH=CHC(ET)=O]-(PPH3)2]-CLO4")
| SpectraBase Compound ID | I2vkRHi6o6g |
|---|---|
| InChI | InChI=1S/2C18H15P.C7H5N.C5H7O.ClHO4.Ir.H/c2*1-4-10-16(11-5-1)19(17-12-6-2-7-13-17)18-14-8-3-9-15-18;8-6-7-4-2-1-3-5-7;1-3-5(6)4-2;2-1(3,4)5;;/h2*1-15H;1-5H;1,3H,4H2,2H3;(H,2,3,4,5);;/q;;;;;-1;/p+1 |
| InChIKey | NBZQOPGPYHUIAU-UHFFFAOYSA-O |
| Mol Weight | 1005.51 g/mol |
| Molecular Formula | C48H45ClIrNO5P2 |
| Exact Mass | 1005.209074 g/mol |
| Parent InChIKey | LWZUDKSPYFTXAV-UHFFFAOYSA-O |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
IR-H-(CL)[KAPA(2)-(C,O)-C(ME)=C(ME)C(ET)=O]-(PPH3)2
IR-H-(CL)[KAPA(2)-(C,O)-C(OME)=CHC(ME)=O]-(PPH3)2
(1S,4aR,4bS,7R,10aR)-1,4a,7-trimethyl-7-vinyl-3,4,4b,5,6,9,10,10a-octahydro-2H-phenanthrene-1-carboxylic acid
PIMARIC ACID
2H,8H,10H-Benzo[1,2-b:3,4-b':5,6-b'']tripyran-8-one, 6-(hydroxymethyl)-2,2,10,10-tetramethyl-
3-Carboxamido-8-methyl-1,2,3-triazolo[1,5-a]-(1,3,5)-benzotriazepine-5-morpholine
1''-methyl-1'',3''-dihydrodispiro[cyclohexane-1,1'-cyclopentane-3',2''-indole]-3'',4'-dione
1H-naphtho[2,3-d][1,2,3]triazole-4,9-dione, 1-(2-phenylethyl)-, 2-oxide
(p-Aminoanilino)benzolsulfonic acid->(alk)gamma-acid->2-(m-Aminoanilino)ethanol<-gamma acid(alk)<-5-amino-2-
NOSTODIONE-A
| Title | Journal or Book | Year |
|---|---|---|
| Preparation of hydrido(vinyl)iridium(III) complexes from functionalized olefins by CH activation | Canadian Journal of Chemistry | 2006 |